Dermapharm Holding SE buy investresearch
Start price
31.10.23
/
50%
€36.70
Target price
31.10.24
-
Performance (%)
-2.32%
End price
02.07.24
€35.85
Summary
This prediction ended on 02.07.24 with a price of €35.85. With a performance of -2.32%, the BUY prediction for Dermapharm Holding SE by investresearch closed slightly in the red. investresearch has 50% into this predictionDermapharm Holding is a Munich-based pharmaceutical company that develops innovative drug formulations and medical devices. It is listed on the Frankfurt Stock Exchange and has a strong presence in Germany and Europe. The company's product portfolio includes preparations for both prescription and over-the-counter drugs, as well as medical devices used in dermatology and urology. Dermapharm Holding differentiates itself from competitors by focusing on niche markets and developing new products in-house through its research and development activities.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dermapharm Holding SE | 1.604% | 1.604% | 2.288% |
| iShares Core DAX® | 0.396% | -0.010% | 17.421% |
| iShares Nasdaq 100 | 0.881% | -0.819% | 7.914% |
| iShares Nikkei 225® | 1.405% | -3.232% | 12.470% |
| iShares S&P 500 | 0.259% | -0.051% | 2.814% |
Comments by investresearch for this prediction
In the thread Dermapharm Holding SE diskutieren
investresearch hat das Wertpapier Dermapharm Holding SE in seinem Wikifolio Nachhaltige Dividendenstars gekauft.